Home | About Us | FAQ's | Careers | Contact Us | Site Map Thursday, September 9, 2010
 
News
WYFF: Good reason to be legally high?
Cancer Centers of the Carolinas receives national award for patient care
CCC raises more than $30,000 for Relay for Life
CCC Employee Shaves Her Head For Cancer Awareness
Updated Results of STAR Study of Raloxifene, Tamoxifen Released
CCC holds second annual bachelor auction
SC Supreme Court affirms approval of CON for CCC Spartanburg
Men, women should be screened for colorectal cancer
CCC welcomes new medical oncologist, Saeeda Z. Chowdhury, M.D.
South Carolina Supreme Court Hears Cancer Treatment Dispute
Dr. Puls writes book about experiences in caring for cancer
CCC Welcomes Shirnett Matthews, M.D., Radiation Oncologist
Cancer as a Turning Point CDs Available
Radiation therapy available for first time in Greer
David Grisell, D.O. joins CCC as radiation oncologist
Heather Bowers, RN, APRN Joins CCC
Leanne Gottschalk, RN, FNP Joins CCC
Article from Dr. Jeffrey Giguere on CCC
Notice of Phony Checks
CCC is on Twitter!
Lisa Johnson-Losinski, RN, ANP Joins CCC
COBRA Premium Subsidy Notice
CCC holds first ever bachelor auction
CCC Welcomes Dr. Gardziola, Medical Oncologist
CCC Now Offers Wireless Internet
Drs. Edenfield & Stephenson Relocate to Faris
CCC Relocates Greer Office
CCC welcomes additional medical oncologist
Transplant Program Receives FACT Accreditation
Cancer Centers of the Carolinas introduces HDR Brachytherapy
Transplant Program Now Participating in Blue Distinction Center Program
Lisa Smith, NP presents a Multiple Myeloma Webcast
Lisa Smith, NP Participates in IMF Poster Presentation
Patient Satisfaction Surveys
Welcome Dr. Suzanne Fanning
Cancer Centers of the Carolinas introduces PET/CT
Vanessa Adams Wins Susan Adams Customer Service Award
Cancer Centers of the Carolinas Wins Prestigious Clinical Trial Award
Gynecologic Oncology Associates Joins Cancer Centers of the Carolinas
American Cancer Society Prevention Study at Relay
Colorectal Cancer Screening
Medicare Advantage Plans
Cancer as a Turning Point returns to Greenville, SC
Employees Earn BCIP Certification
Patrick Sullivan - STAR of the Year
Breathe Easy Campaign
Relay for Life on ABC
Research Accrual Award
Hospice House Fundraiser
Smoking Ban Hearing
Susan Adams Customer Service Award Winner - Becky Briggs
New Physician - Sam Wood, MD
NOW OPEN - New Spartanburg Office
Lisa Smith Presentation
Relay for Life
STAR Clinical Trial Results Announced
Dr. Edenfield and Dr. O'Rourke Receive Prestigious Certification
New Spartanburg Location
Annual mammograms are key to beating breast cancer
Novalis Educational CD-ROM
Greenville CCOP Celebrates 10th Anniversary
Consult CCC Financial Counselor before changing your Medicare Benefits
Transplant Program Receives Prestigious Accreditation
CRU Approved for Biological Trial
Patient receives a new drug in the Clinical Research Unit to help with chemo side effects.
Clinical Research Unit Open House
Cancer Centers of the Carolinas offers Novalis - state-of-the-art technology.
The Centers for Medicare and Medicaid Services (CMS) announce new initiatives for cancer care.
Cancer Centers of the Carolinas Plays Major Role in Testing of Newly Approved Colon Cancer Therapy, AvastinĀ®
Events
Locations and Directions
Our Physicians
Our Nurse Practitioners
Our Services
Bone Marrow Transplant
Clinical Research
Patients and the Public
Support Groups
Useful Cancer Links
Medical Professionals
Patient Education
 
 
 
News
Cancer Centers of the Carolinas introduces HDR Brachytherapy
Dawn Smith
 
Monday, December 31, 2007 -
High Dose Rate (HDR) Brachytherapy
 
 
What is HDR brachytherapy?
·          High Dose Rate (HDR) brachytherapy is a leading-edge treatment that allows physicians to deliver precise radiation treatment directly to a patient’s cancerous tumors through the use of catheters, thin, flexible needles or applicators inserted into a body cavity or directly into the tissue.
·          It is a computer-controlled delivery system that optimizes dose distribution to the target. 
·          HDR brachytherapy is frequently used in the treatment of cervical and uterine cancers, intraluminal treatment of certain lung cancers causing bronchial obstructions and obstructing esophageal cancers. It has also recently been shown to be effective for treatment of early stage prostate cancer. 
 
Why is it used?
·          HDR brachytherapy delivers radiation with extreme precision. Advanced imaging allows catheters to be precisely located so the intended dose can be delivered to a position with 1-millimeter accuracy.
·          Unlike low dose rate brachytherapy treatment, HDR brachytherapy can often be delivered on an outpatient basis and no radioactive material is left in the body. 
·          Treatment times are typically several minutes in duration instead of several days that are required for low dose rate brachytherapy. 
·          Because radiation is delivered directly to the tumor, a higher dose is used, yet exposure to surrounding healthy tissue is limited. HDR brachytherapy results in less than a two percent chance for permanent damage to any of the adjacent normal tissue.
 
How is HDR brachytherapy treatment planned and delivered?
·          The physician determines whether HDR brachytherapy will be administered through a thin catheter, a flexible needle placed through the skin, or through applicators that are inserted into a body cavity such as the lung or esophagus. 
·          Patients are treated in the physician’s office, with sedation if needed, or under anesthesia in the hospital operating room.
·          When catheters are used, treatment may be delivered intermittently over several days. Depending on the type of cancer for which the patient is being treated, catheters could remain in place during treatment, which may last several minutes to several hours. 
·          Following a computed tomography (CT) scan of the treatment area, a three-dimensional reconstruction of the target organ/cancer and adjacent tissue is made to confirm placement of the implant device and plan the delivery sequence of the radioactive source for ideal dose distribution. 
·          The HDR brachytherapy equipment is programmed with the patient’s specific treatment and connected to the implant device with transfer tubes. 
·          Each treatment will last between 10-15 minutes, and during the treatment, the physician and clinical staff continually monitor and communicate with the patient from a room directly outside the treatment room.
·          When treatment is complete, the radioactive source retracts back into the HDR brachytherapy machine, and the transfer tubes are disconnected. For weekly implants or if doses will be delivered weekly, delivery devices are removed and the patient returns home after the procedure. For an implant series extending over several consecutive days, the patient remains in the hospital for comfort and support between treatment deliveries, and delivery devices are removed once the final treatment is complete.
To make a referral, please contact our Radiation Department at our Faris Road Office at 864-679-3900.
 
 
Home | About Us | FAQ's | Contact Us | Site Map

Click here to download our Privacy Policy